Hnhp Biotech India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 63.31%
- Profit Growth 95.47%
- Ebitda -35.98%
- Net Worth 32.02%
- Total Assets 58.72%
About Hnhp Biotech India
Hnhp Biotech India Private Limited (HBIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 24 July 2017 (Seven years and seven months 0 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Hariom Mittal and Neha Mittal serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909UP2017PTC095305
- Company No.
095305
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
What products or services does Hnhp Biotech India Private Limited offer?
Hnhp Biotech India Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, PCR Machine, Chemical Reagents & Catalysts, Inorganic Salts, Plastic & Glass Labware, Volumetric Pipette, Laboratory & Lab Equipment, Laboratory Stirrer, Laboratory Consumables, Corona Test Kit.
Who are the key members and board of directors at Hnhp Biotech India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hariom Mittal  | Director | 24-Jul-2017 | Current |
| Neha Mittal | Director | 05-Jan-2024 | Current |
Financial Performance of Hnhp Biotech India.
Hnhp Biotech India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 63.31% increase. The company also saw a substantial improvement in profitability, with a 95.47% increase in profit. The company's net worth Soared by an impressive increase of 32.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hnhp Biotech India?
In 2019, Hnhp Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hnhp Biotech India?
Unlock and access historical data on people associated with Hnhp Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hnhp Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hnhp Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
